OTCMKTS:DSRLFDiaSorin Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding DiaSorin SpA Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $190.00 0.00 (0.00 %) (As of 05/29/2020 04:00 PM ET) Add Compare Share Today's Range$190.00Now: $190.00▼$190.0050-Day Range$125.00MA: $164.43▼$217.0052-Week Range$114.50Now: $190.00▼$217.00Volume88 shsAverage Volume123 shsMarket Capitalization$10.63 billionP/E RatioN/ADividend YieldN/ABeta0.97 ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlinesSocial Media DiaSorin S.p.A. develops, produces, and commercializes diagnostic tests in various clinical areas for hospital and private testing laboratories in the market of immunodiagnostics and molecular diagnostics. It offers immunodiagnostics products in the areas of infectious diseases; bone and mineral metabolism; endocrinology, including diabetes, thyroid function, fertility, growth, adrenal function, and gastroenterology; hypertension; oncology; stool diagnostics; autoimmunity; and cardiac and brain damages. The company's immunodiagnostics systems include LIAISON XL, an automated chemiluminescence analyzer; LIAISON analyzer; EVOlyzer 2-150/8 with disposable tips to automate microplate based assays; and ETI Max 3000, an automated microtiter plate analyzer. It also offers molecular diagnostic products LIAISON MDX a thermocycler; and LIAISON IAM, an instrument for amplification of nucleic acids, as well as kits, PCR master mixes, primer pairs, and molecular controls for monitoring oncology and infectious diseases. The company sells its products directly, as well as through an international network of independent distributors in Europe, Africa, North Americam Central America, South America, and the Asia Pacific. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for DiaSorin. Previous Next 2.1 Community Rank Outperform VotesDiaSorin has received 68 “outperform” votes. (Add your “outperform” vote.)Underperform VotesDiaSorin has received 94 “underperform” votes. (Add your “underperform” vote.)Community SentimentDiaSorin has received 58.02% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about DiaSorin and other stocks. Vote “Outperform” if you believe DSRLF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe DSRLF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldDiaSorin does not currently pay a dividend.Dividend GrowthDiaSorin does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, DiaSorin insiders have not sold or bought any company stock. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for DiaSorin are expected to grow by 26.34% in the coming year, from $3.91 to $4.94 per share.Price to Book Value per Share RatioDiaSorin has a P/B Ratio of 12.77. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.67 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Private households Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:DSRLF Previous Symbol CUSIPN/A CIKN/A Webwww.diasoringroup.com Phone390-161-4871Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$790.32 million Price / Sales13.45 Cash Flow$4.41 per share Price / Cash Flow43.08 Book Value$14.88 per share Price / Book12.77Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees1,928 Outstanding Shares55,950,000Market Cap$10.63 billion Next Earnings DateN/A OptionableNot Optionable OTC:DSRLF Rates by TradingView Receive DSRLF News and Ratings via Email Sign-up to receive the latest news and ratings for DSRLF and its competitors with MarketBeat's FREE daily newsletter. DiaSorin (OTCMKTS:DSRLF) Frequently Asked Questions How has DiaSorin's stock been impacted by COVID-19 (Coronavirus)? DiaSorin's stock was trading at $122.5186 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, DSRLF stock has increased by 55.1% and is now trading at $190.00. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of DiaSorin? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DiaSorin in the last year. There are currently 1 sell rating and 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for DiaSorin. Has DiaSorin been receiving favorable news coverage? Media coverage about DSRLF stock has trended very negative this week, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. DiaSorin earned a news sentiment score of -3.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutDiaSorin. Who are some of DiaSorin's key competitors? Some companies that are related to DiaSorin include DEUTSCHE POST A/S (DPSGY), Muenchener Ruckvrschrg Gslcht AG Mch (MURGY), China Shenhua Energy (CSUAY), Bayerische Motoren Werke (BAMXF), HENKEL AG & CO/S (HENKY), Hoya (HOCPY), JAPAN TOB INC/ADR (JAPAY), SMC CORP JAPAN/S (SMCAY), Sun Hung Kai Properties (SUHJY), ITOCHU CORP/ADR (ITOCY), SANDS CHINA Ltd/ADR (SCHYY), EXPERIAN PLC/ADR (EXPGY), SWATCH GRP AG/ADR (SWGAY), DENSO CORP/ADR (DNZOY) and SEVEN & I HOLDI/ADR (SVNDY). View all competitors. Who are DiaSorin's key executives? DiaSorin's management team includes the following people: Mr. Carlo Rosa, CEO, GM & Exec. Director (Age 53)Dr. Chen Menachem Even, Chief Commercial Officer & Exec. Director (Age 56)Mr. Piergiorgio Pedron, Corp. Accounting Documents Officer, CFO & Sr. Corp. VP (Age 48)Mr. Riccardo Fava, Sr. Director of Investor Relations & Corp. CommunicationMr. Marco Minolfo, Mang. of the Corp. Legal Affairs Department What is DiaSorin's stock symbol? DiaSorin trades on the OTCMKTS under the ticker symbol "DSRLF." How do I buy shares of DiaSorin? Shares of DSRLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is DiaSorin's stock price today? One share of DSRLF stock can currently be purchased for approximately $190.00. How big of a company is DiaSorin? DiaSorin has a market capitalization of $10.63 billion and generates $790.32 million in revenue each year. DiaSorin employs 1,928 workers across the globe. What is DiaSorin's official website? The official website for DiaSorin is www.diasoringroup.com. How can I contact DiaSorin? DiaSorin's mailing address is Via Crescentino, Saluggia L6, 13040. The company can be reached via phone at 390-161-4871 or via email at [email protected] This page was last updated on 5/31/2020 by MarketBeat.com Staff
